These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26038989)

  • 21. [Clinical guidelines of diagnosis and treatment of hepatitis C].
    Rev Gastroenterol Mex; 2007; 72(2):177-91. PubMed ID: 17966381
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of patients with hepatitis C and cirrhosis.
    Wright TL
    Hepatology; 2002 Nov; 36(5 Suppl 1):S185-94. PubMed ID: 12407593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of glomerulonephritis associated with hepatitis C virus in patient with cirrhosis: only pegylated interferon and ribavirin.
    Taş A; Koçak E; Akbal E; Köklü S
    Chin Med J (Engl); 2011 May; 124(10):1600. PubMed ID: 21740828
    [No Abstract]   [Full Text] [Related]  

  • 24. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCV genotype 5: epidemiology and spread of an uncommon genotype.
    Verbeeck J; Peigue-Lafeuille H; Ross RS; Abergel A; Nevens F; Van der Merwe S; Van Ranst M; Henquell C
    J Clin Virol; 2008 Feb; 41(2):170-1. PubMed ID: 18069057
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical management of asymptomatic HCV carriers].
    Nakamura I; Ochiai K; Imawari M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):396-9. PubMed ID: 15359829
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis C therapy: a problem almost solved].
    Rizzetto M
    Recenti Prog Med; 2014 Jun; 105(6):225-6. PubMed ID: 25002283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of chronic hepatitis C].
    Rókusz L
    Orv Hetil; 2004 Aug; 145(32):1649-53. PubMed ID: 15384863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral hepatitis C in 2014--the beginning of the end?
    Prelipcean CC; Gogălniceanu P; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):272-8. PubMed ID: 25076687
    [No Abstract]   [Full Text] [Related]  

  • 31. Takayasu's arteritis and hepatitis C: a new association?
    Miller EB; Friedman JA
    Clin Rheumatol; 2004 Oct; 23(5):479. PubMed ID: 15459823
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial Commentary: Interferon-free Hepatitis C Treatment Efficacy From Clinical Trials Will Translate to "Real World" Outcomes.
    Martinello M; Dore GJ
    Clin Infect Dis; 2016 Apr; 62(7):927-8. PubMed ID: 26743092
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on combinations of DAAs with and without pegylated-interferon and ribavirin: triple and quadruple therapy more than doubles SVR.
    Martel-Laferrière V; Dieterich DT
    Clin Liver Dis; 2013 Feb; 17(1):93-103. PubMed ID: 23177285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Conclusions].
    Pineda JA
    Enferm Infecc Microbiol Clin; 2013 Jul; 31 Suppl 3():49-50. PubMed ID: 24063903
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
    Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma after sustained viral response to interferon and ribavirin therapy in cirrhosis secondary to chronic hepatitis C.
    Khokhar N; Niazi TK; Qureshi MO
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):699-702. PubMed ID: 24112253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy spectrum in hepatitis C extended. Newer NS3/4A protease inhibitor in chronic hepatitis C-GT1/4 infection].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():53. PubMed ID: 25026860
    [No Abstract]   [Full Text] [Related]  

  • 38. Managing hepatitis C infection in HIV-positive patients.
    Craven DE; Nunes DP
    AIDS Clin Care; 2000 Sep; 12(9):71-5, 78. PubMed ID: 12170952
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of hepatitis C: current status and perspectives].
    Pol S; Corouge M
    Rev Prat; 2014 May; 64(5):605-12. PubMed ID: 24923038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.